St. Jude (STJ) Shares Sink as FDA Receives Report Linking Durata to Cable Defect
Tweet Send to a FriendGet Alerts STJ Hot Sheet
Price: $47.00 +0.38%
Overall Analyst Rating:
NEUTRAL (
Down)
Dividend Yield: 4.3%
EPS Growth %: +7.0%
Overall Analyst Rating:
NEUTRAL (
Down)Dividend Yield: 4.3%
EPS Growth %: +7.0%
Trade STJ Now!
Shares of St. Jude (NYSE: STJ) are plunging midday as Bloomberg is reporting the FDA has received a report linking the company's Durata wire to a cable defect. The report pointed to a single case of an external wire.
The stock is now down 2.6 percent to $37.54.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock is now down 2.6 percent to $37.54.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- St. Jude (STJ) Receives CE Mark for LUMIEN OPTIS PCI System
- Marketo (MKTO) IPO Opens 54% Higher
- Sanofi (SNY) Reports JAKARTA Met Primary Endpoint in Both Groups
Create E-mail Alert Related Categories
FDA, Hot FDA News, Momentum Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
